Verona Pharma plc (VRNA) Misses Q4 EPS by 3c

Verona Pharma plc (NASDAQ: VRNA) reported Q4 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Visa deposits $405M into U.S. litigation escrow, adjusting stock rates
• General Mills beats estimates as cost savings offset volumes